ArticleJournal of the American Heart Association2015
Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.